Literature DB >> 29365278

CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.

Akira Baba1, Tazuko K Goto2, Hiroya Ojiri3, Mutsumi Takagiwa4, Chiho Hiraga5, Masahiro Okamura5, Sho Hasegawa5, Yumi Okuyama1, Nobuhiro Ogino2, Hideomi Yamauchi2, Yuko Kobashi1, Shinji Yamazoe1, Yohei Munetomo1, Takuji Mogami1, Takeshi Nomura5.   

Abstract

OBJECTIVES: Antiresorptive agent-related osteonecrosis of the jaw (ARONJ)/medication-related osteonecrosis of the jaw (MRONJ) include both bisphosphonate-related osteonecrosis of jaw (BRONJ) and denosumab-related osteonecrosis of jaw (DRONJ). The purpose of this study is to study radiological characteristics of ARONJ/MRONJ. These imaging features may serve as one useful aid for assessing ARONJ/MRONJ.
METHODS: CT scans of 74 Japanese patients, who were clinically diagnosed by inclusion criteria of ARONJ/MRONJ, obtained between April 1, 2011 and September 30, 2016, were evaluated. We investigated the CT imaging features of ARONJ/MRONJ, and clarified radiological differentiation between BRONJ and DRONJ, BRONJ due to oral bisphosphonate administration and due to intravenous bisphosphonate administration, BRONJ with respective kinds of medication, BRONJ with long-term administration and short-term administration, BRONJ with each clinical staging respectively. Fisher's exact test, χ2 test, Student's t-test and analysis of variance were performed in the statistical analyses.
RESULTS: Unilateral maxillary sinusitis was detected in all patients with upper ARONJ/MRONJ (100%). DRONJ showed large sequestrum more frequently than BRONJ (3/4, 75 vs 3/35, 8.6%, p < 0.05). DRONJ showed periosteal reaction more frequently than BRONJ (4/10, 40 vs 7/65, 10.1%, p < 0.05). Patients of BRONJ resulting from intravenous bisphosphonate administration showed larger and more frequent buccolingual cortical bone perforations than BRONJ resulting from oral bisphosphonate administration (7/8, 87.5 vs 11/30, 36.7%, p < 0.05). There was no significant correlation between CT findings and respective kinds of medication, long/short-term administration, clinical stages of BRONJ.
CONCLUSIONS: ARONJ/MRONJ has characteristic CT image findings which could be useful for its assessment.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29365278      PMCID: PMC5991756          DOI: 10.1259/dmfr.20170323

Source DB:  PubMed          Journal:  Dentomaxillofac Radiol        ISSN: 0250-832X            Impact factor:   2.419


  35 in total

1.  Mandibular cortical bone evaluation on cone beam computed tomography images of patients with bisphosphonate-related osteonecrosis of the jaw.

Authors:  Sandra R Torres; Curtis S K Chen; Brian G Leroux; Peggy P Lee; Lars G Hollender; Eduardo C A Santos; Shane P Drew; Kuei-Ching Hung; Mark M Schubert
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2012-04-12

2.  Osteonecrosis of the jaw after zoledronic acid and denosumab treatment.

Authors:  Vittorio Fusco; Claudia Galassi; Alfredo Berruti; Libero Ciuffreda; Cinzia Ortega; Giovannino Ciccone; Alberto Angeli; Oscar Bertetto
Journal:  J Clin Oncol       Date:  2011-05-02       Impact factor: 44.544

3.  Can dental panoramic radiographic findings serve as indicators for the development of medication-related osteonecrosis of the jaw?

Authors:  Christoph Klingelhöffer; Manja Klingelhöffer; Steffen Müller; Tobias Ettl; Ulrich Wahlmann
Journal:  Dentomaxillofac Radiol       Date:  2016-05-23       Impact factor: 2.419

4.  Panoramic radiograph, computed tomography or magnetic resonance imaging. Which imaging technique should be preferred in bisphosphonate-associated osteonecrosis of the jaw? A prospective clinical study.

Authors:  Philipp Stockmann; Fabian M Hinkmann; Michael M Lell; Matthias Fenner; Eleftherios Vairaktaris; Friedrich-Wilhelm Neukam; Emeka Nkenke
Journal:  Clin Oral Investig       Date:  2009-06-10       Impact factor: 3.573

5.  Bisphosphonate-associated jawbone osteonecrosis: a correlation between imaging techniques and histopathology.

Authors:  Alberto Bedogni; Stella Blandamura; Zerina Lokmic; Carla Palumbo; Mirko Ragazzo; Francesca Ferrari; Alberto Tregnaghi; Francesco Pietrogrande; Olindo Procopio; Giorgia Saia; Marzia Ferretti; Giorgio Bedogni; Luigi Chiarini; Giuseppe Ferronato; Vito Ninfo; Lucio Lo Russo; Lorenzo Lo Muzio; Pier Francesco Nocini
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2008-03

6.  Computerized tomographic findings in bisphosphonate-associated osteonecrosis of the jaw in patients with cancer.

Authors:  Silvio Diego Bianchi; Matteo Scoletta; Francesca Bozzalla Cassione; Giuseppe Migliaretti; Marco Mozzati
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2007-06-07

Review 7.  A review of bisphosphonate-associated osteonecrosis of the jaws and its management.

Authors:  David K Lam; George K B Sándor; Howard I Holmes; A Wayne Evans; Cameron M L Clokie
Journal:  J Can Dent Assoc       Date:  2007-06       Impact factor: 1.316

Review 8.  Bisphosphonates: mechanism of action and role in clinical practice.

Authors:  Matthew T Drake; Bart L Clarke; Suneep Khosla
Journal:  Mayo Clin Proc       Date:  2008-09       Impact factor: 7.616

Review 9.  Osteonecrosis of the jaw.

Authors:  Ian R Reid; Tim Cundy
Journal:  Skeletal Radiol       Date:  2008-07-23       Impact factor: 2.199

10.  New dimensional staging of bisphosphonate-related osteonecrosis of the jaw allowing a guided surgical treatment protocol: long-term follow-up of 266 lesions in neoplastic and osteoporotic patients from the university of bari.

Authors:  Simonetta Franco; Simona Miccoli; Luisa Limongelli; Angela Tempesta; Giorgio Favia; Eugenio Maiorano; Gianfranco Favia
Journal:  Int J Dent       Date:  2014-06-05
View more
  9 in total

1.  Incidental findings in the thyroid gland on computed tomography images of the oral and maxillofacial region.

Authors:  Abdullah Khasawneh; Yohei Takeshita; Miki Hisatomi; Toshiyuki Kawazu; Mariko Fujita; Shunsuke Okada; Yuri Namba; Yudai Shimizu; Yoshinobu Yanagi; Junichi Asaumi
Journal:  Oncol Lett       Date:  2020-01-13       Impact factor: 2.967

2.  Volumetric analysis of MRONJ lesions by semiautomatic segmentation of CBCT images.

Authors:  Matthias Zirk; Johannes Buller; Joachim E Zöller; Carola Heneweer; Norbert Kübler; Max-Philipp Lentzen
Journal:  Oral Maxillofac Surg       Date:  2019-10-31

Review 3.  Do various imaging modalities provide potential early detection and diagnosis of medication-related osteonecrosis of the jaw? A review.

Authors:  Pongsapak Wongratwanich; Kiichi Shimabukuro; Masaru Konishi; Toshikazu Nagasaki; Masahiko Ohtsuka; Yoshikazu Suei; Takashi Nakamoto; Rinus G Verdonschot; Tomohiko Kanesaki; Pipop Sutthiprapaporn; Naoya Kakimoto
Journal:  Dentomaxillofac Radiol       Date:  2021-01-15       Impact factor: 3.525

Review 4.  Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (4), CT and MR imaging findings of antiresorptive agent-related osteonecrosis of the jaws/medication-related osteonecrosis of the jaw (secondary publication).

Authors:  Akira Baba; Hiroya Ojiri; Tazuko K Goto; Koshi Ikeda; Hideomi Yamauchi; Nobuhiro Ogino; Takuji Mogami
Journal:  Jpn Dent Sci Rev       Date:  2019-02-15

5.  Skeletal Site-Specific Response of Jawbones and Long Bones to Surgical Interventions in Rats Treated with Zoledronic Acid.

Authors:  Jing Yi Wang; Lei Huo; Ru Qing Yu; Nian Jing Rao; Weijia William Lu; Li Wu Zheng
Journal:  Biomed Res Int       Date:  2019-12-18       Impact factor: 3.411

6.  CBCT imaging and histopathological characteristics of osteoradionecrosis and medication-related osteonecrosis of the jaw.

Authors:  Ichiro Ogura; Yoshiyuki Minami; Junya Ono; Yoriaki Kanri; Yasuo Okada; Kensuke Igarashi; Maiko Haga-Tsujimura; Ken Nakahara; Eizaburo Kobayashi
Journal:  Imaging Sci Dent       Date:  2021-01-29

7.  Inhibition of RANKL and Sema4D improves residual ridge resorption in mice.

Authors:  Meri Hisamoto; Shunsuke Kimura; Kai Iwata; Toshihiko Iwanaga; Atsuro Yokoyama
Journal:  Sci Rep       Date:  2022-03-08       Impact factor: 4.379

8.  A Comparison of the Clinical and Radiological Extent of Denosumab (Xgeva®) Related Osteonecrosis of the Jaw: A Retrospective Study.

Authors:  Zineb Assili; Gilles Dolivet; Julia Salleron; Claire Griffaton-Tallandier; Claire Egloff-Juras; Bérengère Phulpin
Journal:  J Clin Med       Date:  2021-05-28       Impact factor: 4.241

Review 9.  Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (1), role of imaging in drug-related osteonecrosis of the jaw: An up-to-date review (secondary publication).

Authors:  Makoto Tsuchimochi; Tohru Kurabayashi
Journal:  Jpn Dent Sci Rev       Date:  2019-01-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.